PROTOCOLOS CLÍNICOS E DIRETRIZES TERAPÊUTICAS

Fibrose cística - Manifestações Pulmonares Fibrose cística - Manifestações Pulmonares placebo-controlled trial of dornase alfa in young patients with cystic fibrosis with mild lung function abnormalities. J Pediatr. 2001;139(6):813-20. 19. Frederiksen B, Pressler T, Hansen A, Koch C, Høiby N. Effect of aerosolized rhDNase (Pulmozyme) on pulmonary colonization in patients with cystic fibrosis. Acta Paediatr. 2006;95(9):1070-4. 20. Hodson ME, McKenzie S, Harms HK, Koch C, Mastella G, Navarro J, et al. Dornase alpha in the treatment of cystic fibrosis in Europe: a report from the Epidemiologic Registry of Cystic Fibrosis. Pediatr Pulmonol. 2003;36(5):427-32. 21. Suri R, Metcalfe C, Wallis C, Bush A. Predicting response to rhDNase and hypertonic saline in children with cystic fibrosis. Pediatr Pulmonol. 2004;37(4):305-10. 22. Shah PL, Conway S, Scott SF, Rainisio M, Wildman M, Stableforth D, et al. A case-controlled study with dornase alfa to evaluate impact on disease progression over a 4-year period. Respiration. 2001;68(2):160-4. 23. Konstan MW, Wagener JS, Pasta DJ. Pulmozyme (Dornase alfa) use is associated with a slower rate of lung function decline in patients with cystic fibrosis [abstract]. Pulmonol Suppl. 2006;29:337. 24. Geller DE, Eigen H, Fiel SB, Clark A, Lamarre AP, Johnson CA, et al. Effect of smaller droplet size of dornase alfa on lung function in mild cystic fibrosis. Dornase Alfa Nebulizer Group. Pediatr Pulmonol. 1998;25(2):83-7. 25. Fitzgerald DA, Hilton J, Jepson B, Smith L. A crossover, randomized, controlled trial of dornase alfa before versus after physiotherapy in cystic fibrosis. Pediatrics. 2005;116(4):e549-54. Epub 2005 Sep 1. 26. Van der Giessen LJ, de Jongste JC, Gosselink R, Hop WC, Tiddens HA. RhDNase before airway clearance therapy improves airway patency in children with CF. Pediatr Pulmonol. 2007;42(7):624-30. 27. Touleimat BA, Conoscenti CS, Fine JM. Recombinant human DNase in management of lobar atelectasis due to retained secretions. Thorax. 1995;50(12):1319-21. 28. SlatteryDM,WaltzDA, DenhamB, O’MahonyM, GreallyP. Bronchoscopically administered recombinant human DNase for lobar atelectasis in cystic fibrosis. Pediatr Pulmonol. 2001;31(5):383-8. 29. Robinson TE, Goris ML, Zhu HJ, Chen X, Bhise P, Sheikh F, et al. Dornase alfa reduces air trapping in children with mild cystic fibrosis lung disease: a quantitative analysis. Chest. 2005;128(4):2327-35. 327